LifeTech Scientific Corporation (LIFETECH SCI) has convened a board meeting for 28 August 2026 to address several key matters.

The agenda includes: 1. Approval of the Group’s unaudited interim results for the six months ended 30 June 2026 and authorisation to publish the results on the websites of Hong Kong Exchanges and Clearing Limited and the Company. 2. Consideration of an interim dividend distribution. 3. Potential closure of the Company’s register of members. 4. Discussion of any additional business items.

The meeting notice was authorised by Executive Director, Chairman and Chief Executive Officer Mr. Xie Yuehui on 12 August 2026. The Board currently comprises three executive directors—Mr. Xie Yuehui, Ms. Wu Liping and Mr. Fang Yu—and three independent non-executive directors—Mr. Zhou Luming, Ms. Chen Dongxia and Mr. Jiang Feng.